A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy
暂无分享,去创建一个
Jacob T. Munro | Angharad M Roberts | J. Seidman | S. Cook | C. Hayward | D. Fatkin | E. Giannoulatou | C. Seidman | S. DePalma | A. Roberts | Michael G Parfenov | F. Mazzarotto | P. Barton | B. McDonough | A. Keogh | D. Herman | L. Felkin | L. Lam | P. Macdonald | Angharad M. Roberts | A. Haghighi | Renee Johnson | C. Horvat | S. Cook | Peter S. Macdonald
[1] L. Mestroni,et al. Dilated Cardiomyopathy: Genetic Determinants and Mechanisms , 2017, Circulation research.
[2] Matthew S. Lebo,et al. Electronic Health Record Phenotype in Subjects with Genetic Variants Associated with Arrhythmogenic Right Ventricular Cardiomyopathy: A Study in 30,716 Subjects with Exome Sequencing , 2017, Genetics in Medicine.
[3] D. MacArthur,et al. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples , 2016, Genetics in Medicine.
[4] Karen S. Frese,et al. Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals , 2017, Clinical Research in Cardiology.
[5] Y. Pinto,et al. A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism. , 2016, Cardiovascular research.
[6] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[7] M. Boutjdir,et al. Mutations in the Voltage Sensors of Domains I and II of Nav1.5 that are Associated with Arrhythmias and Dilated Cardiomyopathy Generate Gating Pore Currents , 2015, Front. Pharmacol..
[8] Heidi L Rehm,et al. ClinGen--the Clinical Genome Resource. , 2015, The New England journal of medicine.
[9] R. Foisner,et al. Lamins: nuclear intermediate filament proteins with fundamental functions in nuclear mechanics and genome regulation. , 2015, Annual review of biochemistry.
[10] R. Gibbs,et al. Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. , 2015, Human molecular genetics.
[11] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[12] Karen S. Frese,et al. Atlas of the clinical genetics of human dilated cardiomyopathy. , 2014, European heart journal.
[13] L. Mestroni,et al. Decreased Levels of BAG3 in a Family With a Rare Variant and in Idiopathic Dilated Cardiomyopathy , 2014, Journal of cellular physiology.
[14] Sivakumar Gowrisankar,et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing , 2014, Genetics in Medicine.
[15] J. Seidman,et al. Genetics and disease of ventricular muscle. , 2014, Cold Spring Harbor perspectives in medicine.
[16] D. Hedges,et al. Dilated cardiomyopathy: the complexity of a diverse genetic architecture , 2013, Nature Reviews Cardiology.
[17] D. Goldstein,et al. Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes , 2013, PLoS genetics.
[18] Euan A Ashley,et al. Cardiac Structural and Sarcomere Genes Associated With Cardiomyopathy Exhibit Marked Intolerance of Genetic Variation , 2012, Circulation. Cardiovascular genetics.
[19] Stefan A. Mann,et al. R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy. , 2012, Journal of the American College of Cardiology.
[20] Donald Wolfgeher,et al. Population-Based Variation in Cardiomyopathy Genes , 2012, Circulation. Cardiovascular genetics.
[21] Jing Hu,et al. SIFT web server: predicting effects of amino acid substitutions on proteins , 2012, Nucleic Acids Res..
[22] P. Ellinor,et al. RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing , 2012, Nature Medicine.
[23] Deborah A Nickerson,et al. Evaluating Pathogenicity of Rare Variants From Dilated Cardiomyopathy in the Exome Era , 2012, Circulation. Cardiovascular genetics.
[24] J. Caldwell,et al. SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism. , 2011, Journal of the American College of Cardiology.
[25] L. Fauchier,et al. A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. , 2011, European heart journal.
[26] Deborah A Nickerson,et al. Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. , 2011, American journal of human genetics.
[27] Toshio Kitazawa,et al. BAG3 and Hsc70 Interact With Actin Capping Protein CapZ to Maintain Myofibrillar Integrity Under Mechanical Stress , 2010, Circulation research.
[28] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[29] D. Waggoner,et al. Sarcomere Mutations in Cardiomyopathy With Left Ventricular Hypertrabeculation , 2009, Circulation. Cardiovascular genetics.
[30] P. Pellikka,et al. Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. , 2009, Journal of the American College of Cardiology.
[31] Patrick Ruchat,et al. Cardiac Sodium Channel Nav1.5 Is Regulated by a Multiprotein Complex Composed of Syntrophins and Dystrophin , 2006, Circulation research.
[32] Jeffrey L. Anderson,et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. , 2005, JAMA.
[33] L. Mestroni,et al. SCN5A Mutation Associated With Dilated Cardiomyopathy, Conduction Disorder, and Arrhythmia , 2004, Circulation.
[34] Marc A. Thomas,et al. Cardiac Voltage-Gated Sodium Channel Nav1.5 Is Regulated by Nedd4-2 Mediated Ubiquitination , 2004, Circulation research.
[35] K. Ohno,et al. Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. , 2004, Brain : a journal of neurology.
[36] S. Solomon,et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. , 2001, The New England journal of medicine.
[37] J. Seidman,et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. , 1999, The New England journal of medicine.
[38] S. Thibodeau,et al. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. , 1998, Science.